Wendy Rubinstein, MD, PhD

Medical Director, Center for Medical Genetics
Division Chief of Medical Genetics
Evanston Northwestern Healthcare

Assistant Professor of Medicine
Feinberg School of Medicine

Research Interests:
Dr. Rubinstein’s clinical and research efforts have focused on hereditary cancer syndromes, with an emphasis on early cancer detection and prevention. While at the University of Pittsburgh she participated in the discovery of the SDHD gene responsible for hereditary paraganglioma, published in Science 2000. Dr. Rubinstein is the recipient of a National Cancer Institute Career Development Award from Northwestern University’s Breast SPORE, focusing on microarray research in breast cancer. Dr. Rubinstein is principal investigator of a study on the clinical utility of breast MRI for early cancer detection in high-risk women. She is Co-Principal Investigator (Co-PI, Suzanne M. O’Neill, PhD) for a Centers for Disease Control-funded multicenter study on “Evaluation of a Family History Tool for Health Promotion and Disease Prevention”. Dr. Rubinstein is co-investigator (PI, Randall Brand, MD) for the ENH Pancreatic Cancer Family Registry. She is co-investigator (PI, Kenneth Bozorgi, MD) for the National Cancer Institute/Gynecologic Oncology Group national study, “Prospective Study of Risk-Reducing Salpingo Oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer (NCI/GOG 0199)”.